BCL2L2 and lymphoma: Compared to control Eμ-Myc lymphomas, those arising in BCL-W-deficient Eμ-Myc mice did not display any notable differences in their immunophenotype, expression of apoptosis-related proteins, or responses to BH3-mimetic drugs.